Hemerion
1 known investors
Hemerion develops a technology to treat brain cancer, specifically glioblastoma, and funds research initiatives led by scientists and clinical teams. The company is expanding into the U.S. healthtech market.
Founders & leadership
MV
Maximilien Vermandel
Investors Β· 1
Frequently asked questions
- What does Hemerion do?
- Hemerion develops a technology to treat brain cancer, specifically glioblastoma, and funds research initiatives led by scientists and clinical teams. The company is expanding into the U.S. healthtech market.
- Who are Hemerion's investors?
- Hemerion's investors include Capital Cell.